Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Charles Quick

Concepts (405)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
143
4.020
Why?
Vulvar Neoplasms
6
2024
61
2.480
Why?
Carcinoma, Squamous Cell
9
2024
332
2.000
Why?
Carcinoma in Situ
7
2022
72
1.740
Why?
Uterine Neoplasms
10
2023
57
1.740
Why?
Carcinoma, Endometrioid
6
2021
38
1.440
Why?
Adenocarcinoma
10
2024
405
1.410
Why?
Tumor Suppressor Protein p53
3
2024
228
1.330
Why?
PAX2 Transcription Factor
7
2015
24
1.280
Why?
Ovarian Neoplasms
10
2024
459
1.060
Why?
Uterine Cervical Neoplasms
7
2024
301
1.060
Why?
Endometrial Hyperplasia
4
2019
14
1.010
Why?
Cannabidiol
6
2024
44
0.970
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2024
62
0.970
Why?
Stromal Cells
2
2016
77
0.910
Why?
Female
66
2024
28792
0.810
Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.800
Why?
Plant Extracts
6
2024
200
0.780
Why?
Myometrium
2
2013
13
0.760
Why?
Endometrium
6
2023
43
0.730
Why?
Adenocarcinoma, Clear Cell
6
2019
35
0.690
Why?
Immunohistochemistry
16
2024
975
0.680
Why?
Precancerous Conditions
3
2019
87
0.670
Why?
Cannabis
6
2024
155
0.660
Why?
Aged, 80 and over
20
2024
3495
0.640
Why?
Humans
70
2024
53246
0.620
Why?
Middle Aged
35
2024
13422
0.620
Why?
Cystadenocarcinoma, Serous
4
2013
73
0.610
Why?
Peripheral Nerves
2
2015
43
0.560
Why?
Mutation
9
2024
1338
0.530
Why?
Aged
29
2024
10430
0.520
Why?
Placenta
6
2021
146
0.510
Why?
Cervix Uteri
2
2017
43
0.500
Why?
Epithelial-Mesenchymal Transition
2
2016
56
0.490
Why?
Adult
31
2024
14541
0.490
Why?
Adenosarcoma
1
2016
3
0.490
Why?
Polyps
1
2016
21
0.480
Why?
Uterine Cervical Dysplasia
1
2016
51
0.470
Why?
Lymphatic Metastasis
6
2019
211
0.450
Why?
Neoplasm Staging
9
2024
774
0.450
Why?
Papillomavirus Infections
3
2024
177
0.450
Why?
Fallopian Tubes
2
2012
22
0.440
Why?
Fibroma
1
2015
41
0.440
Why?
Tumor Microenvironment
4
2021
274
0.430
Why?
Prognosis
11
2024
2118
0.400
Why?
Neoplasm Invasiveness
6
2019
281
0.400
Why?
Observer Variation
4
2024
138
0.390
Why?
Pelvic Neoplasms
1
2011
14
0.350
Why?
Uterus
3
2023
81
0.350
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
89
0.340
Why?
Mice, Inbred C57BL
7
2024
1925
0.320
Why?
Ejaculatory Ducts
1
2010
3
0.320
Why?
Neoplasm Recurrence, Local
4
2015
647
0.320
Why?
Seminal Vesicles
1
2010
13
0.320
Why?
Reproducibility of Results
5
2024
1221
0.310
Why?
Spectrum Analysis, Raman
2
2021
42
0.310
Why?
Prostate
1
2010
118
0.300
Why?
Mice
16
2024
5982
0.300
Why?
Bromcresol Purple
1
2009
3
0.290
Why?
Electrophoresis, Capillary
1
2009
10
0.290
Why?
Serum Albumin
1
2009
56
0.290
Why?
Human papillomavirus 16
2
2021
44
0.280
Why?
Methionine
2
2020
142
0.270
Why?
beta Catenin
2
2021
107
0.270
Why?
Predictive Value of Tests
5
2024
933
0.270
Why?
Disease Progression
4
2020
880
0.270
Why?
Liver
4
2024
1150
0.270
Why?
Diabetes Mellitus
2
2023
321
0.260
Why?
Genital Neoplasms, Female
2
2018
48
0.260
Why?
Anus Neoplasms
2
2018
26
0.260
Why?
Papillomavirus Vaccines
2
2021
74
0.260
Why?
Cell Proliferation
4
2021
1031
0.250
Why?
Metaplasia
2
2019
16
0.250
Why?
Diagnosis, Differential
8
2020
1038
0.250
Why?
Antigens, CD
2
2019
217
0.250
Why?
Prostatic Neoplasms
1
2010
401
0.240
Why?
Melanoma
2
2020
277
0.240
Why?
Colitis
2
2020
49
0.240
Why?
Polyethylene Glycols
2
2017
95
0.230
Why?
Neoplasm Grading
5
2021
128
0.230
Why?
Gold
2
2017
81
0.230
Why?
Hypertension
2
2021
554
0.230
Why?
Animals
17
2024
13528
0.230
Why?
Chi-Square Distribution
2
2016
291
0.220
Why?
Proteomics
3
2017
337
0.220
Why?
Nanoparticles
2
2017
133
0.220
Why?
Aspartic Acid Endopeptidases
2
2015
17
0.210
Why?
Lab-On-A-Chip Devices
1
2024
10
0.210
Why?
Racemases and Epimerases
2
2015
18
0.210
Why?
Sex Cord-Gonadal Stromal Tumors
1
2024
3
0.210
Why?
Young Adult
7
2024
4514
0.210
Why?
Retrospective Studies
11
2020
6821
0.210
Why?
Head and Neck Neoplasms
2
2019
292
0.200
Why?
Carcinoma, Neuroendocrine
1
2024
27
0.200
Why?
Neuroendocrine Tumors
1
2024
25
0.200
Why?
DNA Mutational Analysis
3
2024
179
0.200
Why?
Kidney Neoplasms
2
2018
181
0.200
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
42
0.200
Why?
Chlamydia muridarum
1
2024
39
0.200
Why?
Homeodomain Proteins
1
2024
81
0.200
Why?
Lung Neoplasms
2
2019
645
0.190
Why?
Endometriosis
1
2023
15
0.190
Why?
Chlamydia Infections
1
2024
75
0.190
Why?
Gynecology
2
2020
52
0.190
Why?
Adenocarcinoma, Sebaceous
1
2022
7
0.190
Why?
Sebaceous Gland Neoplasms
1
2022
16
0.190
Why?
CD4-Positive T-Lymphocytes
1
2024
166
0.180
Why?
Hepatocytes
2
2024
188
0.180
Why?
Fallopian Tube Neoplasms
2
2012
15
0.180
Why?
Immunotherapy
2
2021
266
0.180
Why?
Gestational Trophoblastic Disease
2
2012
2
0.180
Why?
CTLA-4 Antigen
1
2021
32
0.170
Why?
Genotype
2
2021
563
0.170
Why?
Estrogens
2
2023
224
0.170
Why?
Fetal Membranes, Premature Rupture
1
2021
22
0.170
Why?
Oncogene Fusion
1
2021
4
0.170
Why?
PTEN Phosphohydrolase
3
2020
55
0.170
Why?
Transcription Factors
3
2020
571
0.170
Why?
Leiomyosarcoma
1
2021
22
0.170
Why?
Diabetes, Gestational
1
2021
52
0.170
Why?
Cancer Vaccines
1
2021
79
0.160
Why?
Carcinosarcoma
2
2017
18
0.160
Why?
Infant, Small for Gestational Age
1
2020
35
0.160
Why?
Carcinoma, Papillary
1
2020
50
0.160
Why?
Neoplasms, Experimental
1
2020
112
0.160
Why?
Carcinoma, Transitional Cell
1
2020
54
0.160
Why?
Pregnancy in Diabetics
1
2020
24
0.150
Why?
Colonic Neoplasms
1
2021
162
0.150
Why?
Radiotherapy
1
2020
126
0.150
Why?
Dermatology
1
2020
54
0.150
Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.150
Why?
Pregnancy Complications, Neoplastic
1
2019
21
0.150
Why?
Carcinoma, Lewis Lung
1
2019
10
0.150
Why?
Placenta Diseases
1
2019
13
0.150
Why?
Premature Birth
1
2021
149
0.150
Why?
Carcinoma, Renal Cell
2
2018
112
0.150
Why?
Skin Diseases
1
2020
117
0.150
Why?
Melanoma, Experimental
1
2019
34
0.150
Why?
Odds Ratio
3
2015
567
0.150
Why?
Hodgkin Disease
1
2019
45
0.150
Why?
T-Lymphocytes
1
2021
320
0.150
Why?
Hepatic Veno-Occlusive Disease
1
2019
11
0.150
Why?
DNA Polymerase II
1
2019
9
0.150
Why?
Fetal Diseases
1
2019
54
0.150
Why?
DNA Mismatch Repair
1
2019
18
0.150
Why?
Monocytes
1
2019
126
0.150
Why?
Sarcoma
1
2020
72
0.140
Why?
Inflammation
2
2020
653
0.140
Why?
Pregnancy
7
2021
2610
0.140
Why?
Urinary Bladder Neoplasms
1
2020
167
0.140
Why?
Methionine Adenosyltransferase
1
2018
19
0.140
Why?
CD8-Positive T-Lymphocytes
1
2019
145
0.140
Why?
Metformin
1
2020
84
0.140
Why?
Radiation Tolerance
1
2019
78
0.140
Why?
Logistic Models
3
2015
947
0.140
Why?
Disease Models, Animal
6
2020
1517
0.140
Why?
Nuclear Proteins
1
2020
250
0.140
Why?
DNA Helicases
1
2020
148
0.140
Why?
Programmed Cell Death 1 Receptor
1
2018
46
0.130
Why?
Neural Cell Adhesion Molecule L1
1
2017
1
0.130
Why?
Rhabdomyosarcoma
1
2018
13
0.130
Why?
Intestinal Mucosa
2
2020
229
0.130
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
69
0.130
Why?
Tumor Necrosis Factor-alpha
2
2019
392
0.130
Why?
Biopsy
5
2020
600
0.130
Why?
Pathology, Molecular
1
2017
28
0.130
Why?
Hypoglycemic Agents
1
2020
227
0.130
Why?
Neoplastic Cells, Circulating
1
2017
34
0.130
Why?
Osteosarcoma
1
2017
44
0.130
Why?
Pregnancy Complications
1
2021
406
0.120
Why?
DNA-Binding Proteins
2
2016
423
0.120
Why?
Time Factors
3
2021
2992
0.120
Why?
Acetaminophen
1
2019
277
0.120
Why?
Vimentin
1
2016
31
0.120
Why?
Papillomaviridae
1
2017
104
0.120
Why?
Oligonucleotide Array Sequence Analysis
1
2017
412
0.120
Why?
Gene Expression Profiling
2
2019
1112
0.120
Why?
Cadherins
1
2016
62
0.120
Why?
Viral Load
1
2016
83
0.120
Why?
Flow Cytometry
1
2017
400
0.120
Why?
Skin Neoplasms
1
2020
500
0.110
Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
5
0.110
Why?
Male
11
2024
27444
0.110
Why?
Neoplasms, Muscle Tissue
1
2015
12
0.110
Why?
Classification
1
2015
12
0.110
Why?
Colposcopy
1
2015
17
0.110
Why?
Malate Dehydrogenase
1
2014
8
0.110
Why?
Class I Phosphatidylinositol 3-Kinases
3
2024
20
0.110
Why?
Lipogenesis
1
2014
32
0.110
Why?
Cytosol
1
2014
80
0.110
Why?
World Health Organization
1
2015
59
0.110
Why?
Mice, Inbred BALB C
3
2021
310
0.110
Why?
Histones
1
2016
318
0.110
Why?
Neoplasm, Residual
1
2015
171
0.110
Why?
Mammary Neoplasms, Experimental
1
2015
122
0.110
Why?
Multiple Myeloma
1
2009
3082
0.110
Why?
Adolescent
4
2024
6912
0.100
Why?
Obesity
1
2022
1205
0.100
Why?
High-Throughput Nucleotide Sequencing
3
2021
181
0.100
Why?
Antineoplastic Agents
2
2021
1232
0.100
Why?
Gastrointestinal Tract
1
2014
110
0.100
Why?
Intestines
1
2014
159
0.100
Why?
Cell Line, Tumor
4
2020
1470
0.100
Why?
Oncogenes
1
2013
61
0.100
Why?
Patient Selection
1
2015
273
0.100
Why?
Membrane Proteins
1
2015
333
0.100
Why?
Clusterin
1
2012
8
0.100
Why?
Dose-Response Relationship, Drug
3
2024
1367
0.090
Why?
Pancreatic Neoplasms
1
2015
219
0.090
Why?
Risk Factors
3
2015
4018
0.090
Why?
Histocytochemistry
1
2012
44
0.090
Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
26
0.090
Why?
Follow-Up Studies
2
2016
2318
0.090
Why?
Strongyloidiasis
1
2012
9
0.090
Why?
Treatment Outcome
3
2021
5597
0.090
Why?
Prednisone
1
2012
101
0.090
Why?
Cytomegalovirus Infections
1
2012
49
0.090
Why?
Vascular Endothelial Growth Factor A
1
2012
189
0.090
Why?
Tissue Inhibitor of Metalloproteinases
1
2011
11
0.080
Why?
Teratoma
1
2011
22
0.080
Why?
Matrix Metalloproteinases
1
2011
47
0.080
Why?
Sensitivity and Specificity
3
2020
869
0.080
Why?
Image Processing, Computer-Assisted
1
2012
235
0.080
Why?
Adenoma, Oxyphilic
1
2010
11
0.080
Why?
Phenotype
3
2019
803
0.080
Why?
Tissue Array Analysis
3
2015
45
0.080
Why?
Glucocorticoids
1
2012
236
0.080
Why?
Tumor Cells, Cultured
2
2021
441
0.080
Why?
Epigenesis, Genetic
1
2012
412
0.070
Why?
Infant, Newborn
3
2021
2913
0.070
Why?
Pilot Projects
2
2023
727
0.070
Why?
Pregnancy Outcome
2
2021
231
0.070
Why?
Phosphatidylinositol 3-Kinases
2
2024
148
0.070
Why?
Necrosis
2
2024
169
0.070
Why?
Telemedicine
1
2015
512
0.070
Why?
Cell Differentiation
2
2024
681
0.070
Why?
Hysterectomy
2
2021
91
0.070
Why?
Cell Nucleus
2
2021
187
0.070
Why?
Host-Pathogen Interactions
2
2021
135
0.070
Why?
Societies, Medical
2
2019
207
0.070
Why?
Gene Expression Regulation
3
2023
1003
0.060
Why?
Neoplasms
1
2017
1335
0.060
Why?
Consensus
2
2020
206
0.060
Why?
Ventricular Pressure
1
2006
16
0.060
Why?
Isoproterenol
1
2006
55
0.060
Why?
Kaplan-Meier Estimate
2
2018
487
0.060
Why?
Terminology as Topic
2
2018
72
0.060
Why?
Combined Modality Therapy
2
2020
640
0.060
Why?
Serum Response Factor
1
2006
45
0.060
Why?
Kidney
1
2010
717
0.060
Why?
Practice Guidelines as Topic
2
2019
502
0.060
Why?
Neoplasm Metastasis
2
2018
237
0.060
Why?
Cytokines
2
2020
627
0.060
Why?
Cells, Cultured
2
2021
1569
0.050
Why?
Proportional Hazards Models
2
2017
445
0.050
Why?
Chromatography, Liquid
2
2016
245
0.050
Why?
Bilirubin
1
2024
43
0.050
Why?
Species Specificity
1
2024
191
0.050
Why?
Tandem Mass Spectrometry
2
2016
255
0.050
Why?
Heart
1
2006
350
0.050
Why?
Steroids
1
2024
61
0.050
Why?
Interleukin-10
1
2024
81
0.050
Why?
Th1 Cells
1
2024
50
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2018
868
0.050
Why?
Phylogeny
1
2024
231
0.050
Why?
Government Agencies
1
2022
15
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
65
0.050
Why?
Hemorrhage
1
2024
226
0.050
Why?
Choriocarcinoma
2
2012
7
0.040
Why?
Genes, T-Cell Receptor
1
2021
5
0.040
Why?
Uterine Hemorrhage
1
2021
7
0.040
Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.040
Why?
Parturition
1
2021
51
0.040
Why?
Phthalazines
1
2021
20
0.040
Why?
Remission Induction
1
2021
222
0.040
Why?
Quinazolines
1
2021
34
0.040
Why?
Lymphocyte Activation
1
2021
163
0.040
Why?
Vulva
1
2020
18
0.040
Why?
Taurine
1
2020
18
0.040
Why?
Research Report
1
2020
19
0.040
Why?
Metabolic Networks and Pathways
1
2021
90
0.040
Why?
Herb-Drug Interactions
1
2020
31
0.040
Why?
Mucin-2
1
2020
8
0.040
Why?
Toxicity Tests
1
2020
57
0.040
Why?
Risk
1
2021
306
0.040
Why?
Alkaline Phosphatase
1
2020
92
0.040
Why?
Piperazines
1
2021
125
0.040
Why?
Molecular Targeted Therapy
1
2021
138
0.040
Why?
Chemokines
1
2020
78
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
579
0.040
Why?
Birth Weight
1
2020
119
0.040
Why?
United States
3
2016
5413
0.040
Why?
Preoperative Period
1
2020
47
0.040
Why?
Chorionic Villi
1
2019
3
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
36
0.040
Why?
Mice, Transgenic
2
2014
561
0.040
Why?
Colon
1
2020
106
0.040
Why?
Endothelium
1
2019
38
0.040
Why?
Pyrimidines
1
2021
206
0.040
Why?
Chest Pain
1
2019
55
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
59
0.040
Why?
Ultrasonography, Doppler, Color
1
2019
30
0.040
Why?
Cytochrome P-450 Enzyme System
1
2020
191
0.040
Why?
Receptors, Progesterone
1
2020
68
0.040
Why?
Glutamine
1
2020
177
0.040
Why?
Dyspnea
1
2019
78
0.040
Why?
Estrogen Receptor alpha
1
2020
85
0.040
Why?
Fatal Outcome
1
2019
193
0.040
Why?
Liver Function Tests
1
2019
47
0.040
Why?
Mice, Inbred Strains
1
2019
163
0.040
Why?
Drug Synergism
1
2019
147
0.040
Why?
Imaging, Three-Dimensional
1
2019
145
0.040
Why?
Gestational Age
1
2020
394
0.040
Why?
Mice, Nude
1
2019
232
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
228
0.030
Why?
Nephrectomy
1
2018
81
0.030
Why?
Mullerian Ducts
1
2018
4
0.030
Why?
Wolffian Ducts
1
2018
2
0.030
Why?
Mutation Rate
1
2018
36
0.030
Why?
Ultrasonography, Prenatal
1
2019
151
0.030
Why?
Lymph Node Excision
1
2019
132
0.030
Why?
Skin
1
2020
420
0.030
Why?
Cell Lineage
1
2018
90
0.030
Why?
Mixed Tumor, Mullerian
1
2017
3
0.030
Why?
DNA Copy Number Variations
1
2018
117
0.030
Why?
Lymph Nodes
1
2019
252
0.030
Why?
Anal Canal
1
2017
27
0.030
Why?
Macrophages
1
2019
380
0.030
Why?
Dietary Supplements
1
2020
479
0.030
Why?
Disease-Free Survival
1
2017
466
0.030
Why?
Matrix Attachment Region Binding Proteins
1
2017
38
0.030
Why?
Child
2
2024
7384
0.030
Why?
Telomerase
1
2016
26
0.030
Why?
Transcriptome
1
2019
368
0.030
Why?
Vaccines, Subunit
1
2016
15
0.030
Why?
Ontario
1
2016
50
0.030
Why?
Mesonephros
1
2016
1
0.030
Why?
Signal Transduction
1
2023
1748
0.030
Why?
Diet
1
2020
611
0.030
Why?
T-Lymphocytes, Regulatory
1
2016
83
0.030
Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
8
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Antiporters
1
2015
19
0.030
Why?
Leukocytes, Mononuclear
1
2016
122
0.030
Why?
S100 Proteins
1
2015
33
0.030
Why?
Cell Count
1
2015
141
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
68
0.030
Why?
Cell Hypoxia
1
2015
82
0.030
Why?
Pressure
1
2015
102
0.030
Why?
Drug Evaluation, Preclinical
1
2015
142
0.030
Why?
Blood Vessels
1
2015
73
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2015
52
0.030
Why?
Genetic Predisposition to Disease
1
2018
533
0.030
Why?
Prospective Studies
1
2020
2412
0.030
Why?
Random Allocation
1
2015
284
0.030
Why?
Immunoenzyme Techniques
1
2014
134
0.030
Why?
Radiotherapy Dosage
1
2015
249
0.030
Why?
Apoptosis
1
2020
1139
0.030
Why?
Proteome
1
2016
178
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
181
0.030
Why?
Likelihood Functions
1
2014
56
0.030
Why?
In Situ Hybridization, Fluorescence
1
2015
266
0.030
Why?
Multivariate Analysis
1
2015
598
0.030
Why?
Genes, erbB-1
1
2013
9
0.020
Why?
Vaccination
1
2016
310
0.020
Why?
Lipid Metabolism
1
2014
189
0.020
Why?
Anti-Bacterial Agents
1
2019
832
0.020
Why?
Gene Frequency
1
2013
97
0.020
Why?
Adiposity
1
2014
147
0.020
Why?
SEER Program
1
2013
106
0.020
Why?
Mesentery
1
2012
13
0.020
Why?
Communication
1
2015
263
0.020
Why?
Insulin Resistance
1
2014
282
0.020
Why?
Research Design
1
2015
373
0.020
Why?
Neoplasms, Glandular and Epithelial
1
2012
42
0.020
Why?
Rural Health Services
1
2015
179
0.020
Why?
Pregnancy Proteins
1
2012
5
0.020
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
7
0.020
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
8
0.020
Why?
Ovary
1
2012
103
0.020
Why?
Socioeconomic Factors
1
2015
623
0.020
Why?
Angiopoietin-1
1
2012
16
0.020
Why?
Diet, High-Fat
1
2014
243
0.020
Why?
Ivermectin
1
2012
10
0.020
Why?
Angiopoietin-2
1
2012
17
0.020
Why?
Antiparasitic Agents
1
2012
11
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
38
0.020
Why?
Infant
1
2020
3808
0.020
Why?
Algorithms
1
2015
668
0.020
Why?
Hydatidiform Mole
1
2011
1
0.020
Why?
RNA, Messenger
1
2014
1133
0.020
Why?
Interleukin-6
1
2012
272
0.020
Why?
Isoenzymes
1
2011
165
0.020
Why?
Crohn Disease
1
2012
117
0.020
Why?
Promoter Regions, Genetic
1
2012
465
0.020
Why?
Gene Expression
1
2012
618
0.020
Why?
Risk Assessment
1
2015
1368
0.020
Why?
Radiography
1
2011
476
0.020
Why?
Cell Line
1
2012
1016
0.020
Why?
Cohort Studies
1
2013
1557
0.020
Why?
Rats
1
2014
3164
0.020
Why?
DNA Methylation
1
2012
592
0.020
Why?
Blotting, Western
1
2006
587
0.010
Why?
Myocardium
1
2006
471
0.010
Why?
Age Factors
1
2006
1136
0.010
Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description